NHS National Pharmaceuticals Transition 2020_2 Offer reference number: CM/PHG/20/5618 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months) Potential periods of call-offs under the framework agreement Transition Products: LSNE 01/12/2020 to 30/09/2021 (10 months) NWLN 01/12/2020 to 31/01/2022 (14 months) CESW 01/12/2020 to 30/06/2022 (19 months) Hospital Only Products: All Regions 01/12/2020 to 31/01/2022 (14 months)
2nd Floor, Rutland House
Contract value: 43300000
Published: 4 Aug 2020, Receipt by: 3 Sep 2020
All suppliers that are registered with us receive email notifications of Public Sector tenders related to their area of business.